Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant’s Upcoming Depression Data

1 day ago 4

Habib Ur Rehman

Wed, June 17, 2026 astatine 10:17 AM CDT 2 min read

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is 1 of the small-cap stocks with imaginable to emergence 1000 percent. The company's main near-term catalyst is navacaprant, an experimental slump attraction being tested successful patients with large depressive disorder. On May 7, Neumora said 2 late-stage studies, KOASTAL-2 and KOASTAL-3, were afloat enrolled successful the archetypal 4th of 2026, with much than 400 patients successful each trial. The institution expects to study combined top-line results from the 2 studies successful the 2nd 4th of 2026, making the update a large trial of the stock's bull case.

Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant's Upcoming Depression Data

Neumora is besides trying to physique a broader brain-disease pipeline beyond navacaprant. The institution said NMRA-511 remains connected way to study information successful the 2nd fractional of 2026 from a survey successful agitation linked to Alzheimer's disease, with a Phase 2 proceedings expected to statesman successful the archetypal 4th of 2027. Another cause candidate, NMRA-898, is being tested successful steadfast volunteers and patients with unchangeable schizophrenia, with Phase 1 information besides expected successful the 2nd fractional of 2026. Neumora ended the archetypal 4th with $147.1 cardinal successful currency and currency equivalents, which it expects to money operations into the 3rd 4th of 2027.

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is simply a clinical-stage biopharmaceutical institution processing treatments for encephalon diseases, including depression, Alzheimer's-related agitation, and schizophrenia.

While we admit the imaginable of NMRA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article